[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Comment & Response
September 20, 2016

Timing of Initiation of Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury—Reply

Author Affiliations
  • 1Department of Anaesthesiology, Intensive Care Medicine, and Pain Medicine, University Hospital Münster, Germany
  • 2Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, Pennsylvania
JAMA. 2016;316(11):1214. doi:10.1001/jama.2016.11338

In Reply Drs Vinsonneau and Monchi and Dr Wang and colleagues point out that the study designs of the ELAIN and AKIKI1 trials differ. For example, patients in the ELAIN trial were treated earlier and were more severely ill compared with patients in the AKIKI trial. We believe that the pivotal difference between ELAIN and AKIKI is the time at which RRT was initiated. This is important because AKI can result in systemic disease affecting inflammation and function of different organs. Early treatment may attenuate the levels of pro-inflammatory mediators and subsequently reduce organ dysfunction.